Objective: To examine whether glucagon-like peptide-1 receptor agonist (GLP-1 RA) use is associated with reduced risk of kidney replacement therapy (KRT) and health care utilization (HCU) compared with active comparators in adults with bipolar disorder (BD) and chronic kidney disease (CKD; stage ≤3).
Methods: Using Tri...
Balwinder Singh, M. G. Gonzalez Suarez, Hossam M. Ali et al.· Journal of Clinical Psychiat...· 0 citations
Individuals with bipolar disorder (BD) face elevated rates of chronic kidney disease (CKD) and premature mortality yet remain underrepresented in cardiorenal trials. Although sodium-glucose cotransporter-2 inhibitors (SGLT2is) and glucagon-like peptide-1 receptor agonists (GLP-1 RAs) have established renoprotective ben...
Balwinder Singh, Feyza Yaylaci, Hossam M. Ali et al.· Journal of Affective Disorde...· 0 citations
Rigorous RCTs with standardized protocols, larger sample sizes, uniform dosing, and systematic biomarker investigations are needed to clarify ketamine’s neurochemical mechanism and optimize ketamine’s clinical application in treatment-resistant depression.
Balwinder Singh, Hossam M. Ali, Alessandro Miola et al.· Neuropsychopharmacology· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.